Pioneering 3D Human Tissues for Drug Discovery

Mar 27 | 2025

Organovo Provides Business Update

Read More »

Mar 25 | 2025

Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company

Read More »

Mar 19 | 2025

Organovo Announces Reverse Stock Split

Read More »